Want to join the conversation?
$CELG cuts 2015 EPS guidance to $2.02-2.24 from prior estimate of $2.17-2.46, while affirming its adjusted EPS outlook of $4.75-4.85 and net product sales forecast of $9-9.5Bil. $CELG lifts 2015 Revlimid sales outlook to about $5.8Bil from $5.6-5.7Bil, while cutting Abraxane sales guidance to $0.95-1Bil from $1-1.25Bil.
Visa ($V) set to release it earning after market close today. With new CEO resigning so close to the earnings, should we expect to see any surprises? Visa has been making strong moves with Visa Europe acquisition, partnership with PayPal and a 15% increase if quarterly dividends.
Kimberly Clark Corp ($KMB) has been in decline for most of the year, the stock has also not been getting any analyst love. Will today’s earnings break the trend? Revenue has been up and down in the last four quarters, let us see what this quarter brings.
$KMB down close to 4% after it misses on earnings and revenue. Forecasts are lower for the year.